Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1990;10:531-534

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barrett-Connor, E.
Right arrow Articles by Laakso, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barrett-Connor, E.
Right arrow Articles by Laakso, M.

Arteriosclerosis, Vol 10, 531-534, Copyright © 1990 by American Heart Association


ARTICLES

Ischemic heart disease risk in postmenopausal women. Effects of estrogen use on glucose and insulin levels

E Barrett-Connor and M Laakso
Department of Community and Family Medicine, University of California, San Diego, La Jolla 92093.

We report the fasting and post-challenge plasma insulin and glucose levels in 469 nondiabetic postmenopausal women from the Rancho Bernardo cohort according to the current use of estrogen replacement therapy. In these older women, the use of noncontraceptive estrogen was not associated with impaired glucose tolerance. Estrogen-treated women had lower levels of insulin than women who were not taking estrogen; these differences were not explained by age, obesity, or differential hormone use by women with known glucose intolerance. There were no significant differences in glucose and insulin levels in those taking conjugated equine estrogen (Premarin) alone compared to those taking it with medroxyprogesterone acetate (Provera).


This article has been cited by other articles:


Home page
Diabetes CareHome page
M. Otsuki, S. Kasayama, H. Saito, M. Mukai, and M. Koga
Sex Differences of Age-Dependent Changes of Insulin Sensitivity in Japanese Nondiabetic Subjects
Diabetes Care, October 1, 2005; 28(10): 2590a - 2591a.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. M. Kanaya, D. Herrington, E. Vittinghoff, F. Lin, D. Grady, V. Bittner, J. A. Cauley, and E. Barrett-Connor
Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial
Ann Intern Med, January 7, 2003; 138(1): 1 - 9.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E.M. Bladbjerg, S.O. Skouby, L.F. Andersen, and J. Jespersen
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor
Hum. Reprod., December 1, 2002; 17(12): 3235 - 3241.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Ferrara, A. J. Karter, L. M. Ackerson, J. Y. Liu, and J. V. Selby
Hormone Replacement Therapy Is Associated With Better Glycemic Control in Women With Type 2 Diabetes: The Northern California Kaiser Permanente Diabetes Registry
Diabetes Care, July 1, 2001; 24(7): 1144 - 1150.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. C. Duncan, H. Lyall, R.N. Roberts, J. R. Petrie, M. J. Perera, S. Monaghan, D. M. Hart, J. M. C. Connell, and M. A. Lumsden
The Effect of Estradiol and a Combined Estradiol/Progestagen Preparation on Insulin Sensitivity in Healthy Postmenopausal Women
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2402 - 2407.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
M. S. Weintraub, I. Grosskopf, G. Charach, N. Eckstein, Y. Ringel, N. Maharshak, H. H. Rotmensch, and A. Rubinstein
Fluctuations of Lipid and Lipoprotein Levels in Hyperlipidemic Postmenopausal Women Receiving Hormone Replacement Therapy
Arch Intern Med, September 14, 1998; 158(16): 1803 - 1806.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
O C E Gebara, M A Mittleman, B W Walsh, I Lipinska, F K Welty, G Bellotti, J E Muller, F K Sacks, and G H Tofler
Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia
Heart, September 1, 1998; 80(3): 235 - 239.
[Abstract] [Full Text]


Home page
CirculationHome page
K. E. Sorensen, I. Dorup, A. P. Hermann, and L. Mosekilde
Combined Hormone Replacement Therapy Does Not Protect Women Against the Age-Related Decline in Endothelium-Dependent Vasomotor Function
Circulation, April 7, 1998; 97(13): 1234 - 1238.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Wagner, M. J. Thomas, J. K. Williams, L. Zhang, K. A. Greaves, and W. T. Cefalu
Insulin Sensitivity and Cardiovascular Risk Factors in Ovariectomized Monkeys with Estradiol Alone or Combined with Nomegestrol Acetate
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 896 - 901.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Andersson, L.-A. Mattsson, L. Hahn, L. Lapidus, G. Holm, B.-A. Bengtsson, and P. Bjorntorp
Estrogen Replacement Therapy Decreases Hyperandrogenicity and Improves Glucose Homeostasis and Plasma Lipids in Postmenopausal Women With Noninsulin-Dependent Diabetes Mellitus
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 638 - 643.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Shahar, A. R. Folsom, V. V. Salomaa, V. L. Stinson, P. G. McGovern, T. Shimakawa, L. E. Chambless, and K. K. Wu
Relation of Hormone-Replacement Therapy to Measures of Plasma Fibrinolytic Activity
Circulation, June 1, 1996; 93(11): 1970 - 1975.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. Salomaa, V. Rasi, J. Pekkanen, E. Vahtera, M. Jauhiainen, E. Vartiainen, C. Ehnholm, J. Tuomilehto, and G. Myllyla
Association of Hormone Replacement Therapy With Hemostatic and Other Cardiovascular Risk Factors : The FINRISK Hemostasis Study
Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1549 - 1555.
[Abstract] [Full Text]


Home page
CirculationHome page
O. C. E. Gebara, M. A. Mittleman, P. Sutherland, I. Lipinska, T. Matheney, P. Xu, F. K. Welty, P. W. F. Wilson, D. Levy, J. E. Muller, et al.
Association Between Increased Estrogen Status and Increased Fibrinolytic Potential in the Framingham Offspring Study
Circulation, April 1, 1995; 91(7): 1952 - 1958.
[Abstract] [Full Text]


Home page
Reproductive SciencesHome page
S. R. Lindheim, T. A. Buchanan, D. M. Duffy, M. A. Vijod, T. Kojima, F. Z. Stanczyk, and R. A. Lobo
Original ArticlesComparison of Estimates of Insulin Sensitivity in Pre- and Postmenopausal Women Using the Insulin Tolerance Test and the Frequently Sampled Intravenous Glucose Tolerance Test
Reproductive Sciences, April 1, 1994; 1(2): 150 - 154.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
S. R. Lindheim, R. S. Legro, R. S. Morris, I. L. Wong, D. Q. Tran, M. A. Vijod, F. Z. Stanczyk, and R. A. Lobo
The Effect of Progestins on Behavioral Stress Responses in Postmenopausal Women
Reproductive Sciences, January 1, 1994; 1(1): 79 - 83.
[Abstract] [PDF]


Home page
NEJMHome page
A. A. Nabulsi, A. R. Folsom, A. White, W. Patsch, G. Heiss, K. K. Wu, M. Szklo, and The Atherosclerosis Risk in Communities Study Inve
Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal Women
N. Engl. J. Med., April 15, 1993; 328(15): 1069 - 1075.
[Abstract] [Full Text]